● Ph.D., Swiss Federal Institute of Technology, Diplom, Heidelberg University, Germany
● Vice-chairman of Pharmaceutical Engineering Committee of Guangdong Pharmaceutical Association Council
● Member of the German Association of Traditional Chinese Medicine
● Guangdong "Pearl river entrepreneur"，Leading Entrepreneurship in Guangzhou Development Zone
● Rich experience in overseas research and industry, familiar with animal cell culture, recombinant protein and recombinant virus expression, etc.
● MSc at Xiamen University
● 30+ years of operation and management experiences in biologics industry
● Accomplished multiple national Class1 new drug registrations and GMP facility establishment
● Successfully led development projects of HPV vaccine and Hepatitis E vaccine
● Established vaccine production line and passed the inspection for new drug registration and GMP production
● EMBA from CEIBS, MBA from Ryerson University, Toronto, Canada
● Engineering background with 20-years experiences in global pharma R&D service companies with management, operation, BD and project management experiences
● Was China General Manager of Catalent and hold key management roles at Cardinal Health China and North America
● Experiences of supporting many global clinical studies for local and global sponsors
● Established GMP facilities and experienced multiple NMPA, European and US GMP inspections
● BBA, BS, JM at Peking University
● 10+ years of experience in investment, financing and corporate management
● Worked as the investment banker at headquarter of Guotai Jun’an Securities, Managing Director of Sailing Capital, Director & Board Secretary of Shapuaisi Pharmaceutical
● Experiences of multiple IPO and financing projects, and multiple private equity’s fundraising, investment, management and exit
● Managed listed companies’ investor relationship, merger and acquisition, and industrial investments
● Ph.D., Martin-Luther-University Halle, Germany
● 20+ years applied protein chemistry expertise in academia and industry
● 10+ years of CMC leadership at Novartis in late stage development, BLA submission, PAI, launch and post approval tLCM of Biosimilar and NBE drugs
● Established concepts for PPQ, continued process verification & comparability
● Ph.D., Biochemistry, Universit?tskrankenhaus Eppendorf
● Post Doc at Hoffmann-La Roche, Nutley, NJ, USA
● Nearly 30 years of experiences at German biotech companies (Nemod, Glycotope)
● Very experienced in clinical bioanalysis and bioassays with immunological and GxP background
● 30+ publications and patents, Member of the GBM (German Society of Biochemistry and Molecular Biology)
● Ph.D., Technical University of Munich
● 20+ years of experiences at German biotech companies
● Scientific expertise in cell line engineering, glyco-biology, bioprocesses
● 20+ publications and patents
● Board member of glycoNet-Berlin/Brandenburg
Please Contact Us for Further Service Details and Quotations！
Copyright ? 2021 Canton Biologics Co., Ltd. ALL RIGHTS RESERVED 粵ICP備16115190號(hào) Designed By Wanhu.
